FAQs on Understanding Bispecifics
Автор: Multiple Myeloma Research Foundation - MMRF
Загружено: 2025-06-11
Просмотров: 212
Описание:
Veronica Bohorquez-Medd, Sr. Manager of Education at the Multiple Myeloma Research Foundation, gets answers to frequently asked questions on bispecific antibody therapy from Cindy Varga, MD (Associate Professor, Atrium Health Levine Cancer Institute, Charlotte, North Carolina); Jordan Robinson, PA-C (Atrium Health Levine Cancer Institute, Charlotte, North Carolina); and Kim Odom, a multiple myeloma patient.
Dr. Varga, Ms. Robinson, and Ms. Odom answer your questions on bispecific antibody therapy, including...
01:10 When is treatment with a bispecific appropriate?
11:00 Access to bispecifics and the treatment process
25:39 Effectiveness of bispecifics and bispecifics clinical trials
29:10 Side effects of bispecifics
41:00 CAR T-cell therapy vs bispecifics and treatment sequencing
54:25 Future of bispecifics and beyond
This session is supported by Adaptive, Alexion, Bristol Myers Squibb, CURE, Genentech, Kite/Arcellx, Pfizer, Regeneron, and Sanofi.
If you have questions, call our MMRF Patient Navigation Center at 1-888-841-6673.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
